Clinical trial
A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01
NCT00583557
Study timeline
Study start (unknown)2005-01-01Date precision: month
Registry last updated2013-08-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
belimumabDRUG · verified · RxNorm: belimumab
Sponsors & collaborators
Human Genome Sciences Inc.lead sponsor
Mapped research locations
Los AngelesCalifornia, United States2DallasTexas, United States2Oklahoma CityOklahoma, United States2WarsawPoland2HoustonTexas, United States1ChicagoIllinois, United States1St LouisMissouri, United States1SeattleWashington, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00583557 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.